Navigation Links
Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results
Date:2/13/2009

19,109,149 20,000,956 Shengtai Pharmaceutical, Inc. Consolidated Balance Sheets As of December 31, 2008 and June 30, 2008 ASSETS December 31, June 30, 2008 2008 (Unaudited) CURRENT ASSETS: Cash $6,881,595 $3,405,606 Restricted cash 6,319,465 6,763,500 Accounts receivable, net of allowance for doubtful accounts of $493,507 and $440,701 as of December 31, 2008 and June 30, 2008, respectively 6,192,651 7,614,236 Notes receivable 703,206 458,630 Other receivables 175,554 691,215 Inventories 6,773,059 5,039,278 Prepayments 217,503 310,381 Loan to related party 440,100 -- Total current assets 27,703,133 24,282,846 PLANT AND EQUIPMENT, net 70,803,112 69,943,021 OTHER ASSETS: Investment in Changle Shengshi Redian Co., Ltd. 3,665,602 3,607,912 Loan to related party - noncurrent -- 437,700 Intangible assets - land use right, net of accumulated amortization 3,032,706 3,042,183 Total other assets 6,698,308 7,087,795 Total assets $105,204,553 $101,313,662 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable
'/>"/>
SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
2. Shengtai Pharmaceutical, Inc. Appoints New CFO
3. Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel
4. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
5. Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
6. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
7. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
9. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
10. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
11. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 AACC, a global scientific and medical ... unveiled an updated brand identity today that reflects the ... changing healthcare environment and continue to do what they ... get the care they need. " ... an essential role in saving lives and making people ...
(Date:8/1/2014)... Once a decision has been made ... will discuss how to define your tolerance for lowest ... Allen, Senior Director of Facilities Integration at Fluor Industrial ... Industrial Services, and special guest Carrier Li, Director in ... as they provide an examination of the Conceptual Design ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... consumers, are increasingly searching for food alternatives that ... nutritional benefits. The food ingredient market has numerous ... players such as Vital Force Technology (VFT). ... more than 4,000 energetic patterns, all tested to ...
(Date:7/31/2014)... famous for a number of breakthroughs, which altered the ... a paper, which laid the foundation of computer science, ... He next played a pivotal role in the Second ... military codes, enabling the Allies to defeat the Nazis ... he turned his attention to artificial intelligence and proposed ...
Breaking Biology Technology:AACC Debuts Refreshed Brand Identity 2Defining Low Cost in Your Solution for Future Facilities, New Webinar for Pharma, Biotech, Medical Device and Healthcare Companies, Hosted by Xtalks 2Functional Ingredient Manufacturer – Vital Force Technology Infuses Raw Materials & Ingredients with Subtle Energy Formula 2A mathematical theory proposed by Alan Turing in 1952 can explain the formation of fingers 2A mathematical theory proposed by Alan Turing in 1952 can explain the formation of fingers 3
... 2011 Informex , the leading meeting place ... details of the Global Pharma Sourcing Conference to be ... Avenue in Philadelphia, Pennsylvania. The two day program will ... CPhI to address key issues that global chemical and ...
... The following is a letter to shareholders from ... a publicly traded portfolio of biotech companies based on ... Dear Fellow Investors, Hadasit Bio-Holdings ... Hadassah University Hospital and its IPO which made public ...
... of recent salmonella outbreaks in the United States: ground ... and the list goes on, according to the U.S. ... for long, thanks to a promising new biosensor nanotechnology ... contaminated food or animals reach the marketplace. In the ...
Cached Biology Technology:Informex Introduces a Thorough Global Pharma Perspectives Conference 2Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 2Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 3Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 4Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 5Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 6
(Date:8/1/2014)... -- LiveScan Service Provider Binary Biometrics is pleased to welcome Kevin ... will improve its mobile service capabilities and add more daily appointments, which will ... service several new cities such as, but not limited to, Daytona ... Deltona , Edgewater , Holly ... Beach , Oak Hill , Orange City ...
(Date:7/31/2014)... by the National Science Foundation (NSF), counters a ... atmospheric warming, indicating instead that certain Arctic lakes ... the atmosphere. , The study, published this ... on thermokarst lakes, which occur as permafrost thaws ... fresh water, converting what was previously frozen land ...
(Date:7/31/2014)... (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity ... (HPV) vaccine Cervarix. Women vaccinated with the ... than nine years, and vaccine efficacy (VE) ... the longest follow-up report for a licensed ... the full paper. , HPV and ...
Breaking Biology News(10 mins):Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris 2Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris 3Certain Arctic lakes store more greenhouse gases than they release 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3
... the membrane of human liver cells that aids in cholesterol ... first step in hepatitis C infection, according to research at ... The cholesterol receptor offers a promising new target for anti-viral ... the researchers, whose findings were reported online in advance of ...
... has taken us a step closer to breeding hardier crops ... off attack from parasites. In a paper published in ... of the United States of America (PNAS), the researchers have ... Arabidopsis thaliana , or thale cress, by controlling an ...
... infants are helpless creatures that only blink, eat, cry ... studies indicate infant brains come equipped with knowledge of ... we study infant knowledge of the world by measuring ... Kristy vanMarle, an assistant professor in the Department of ...
Cached Biology News:Entry point for hepatitis C infection identified 2Improving crops from the roots up 2Babies are born with 'intuitive physics' knowledge, says MU researcher 2
Kit for BASE20/50 dual control unit, includes mounting plate, HOLDER50T, HEATERPAD50, SRTDX temperature probe(s)....
... Situ Assay Kit is a fluorescent-based assay ... undergoing apoptosis. The kit is for research ... or therapeutic procedures. CHEMICON®s CaspaTag™ Pan-Caspase In ... to detect active caspases. The methodology is ...
... This special concentrated jetSI 10 nM ... delivery into mouse brain as described in: ... Alfama, C. Giovannangeli, J.-P. Behr, and B.-A. ... gene expression in the mouse brain at ...
... INTERFERin is a new-generation siRNA transfection reagent ... at 1 nM siRNA in a wide ... excellent cell viability. Using low siRNA concentrations ... observed when transfecting siRNA at higher concentrations, ...
Biology Products: